ABEV logo

ABEV Total Costs & Expenses

Latest reportedR$63.94B BRL
ABEV TTM Total Costs & Expenses · BRL (R$2.72B → R$63.94B)
High-resolution chart · PNG

ABEV total costs & expenses history

Trailing twelve months (TTM) · BRL. Each value covers four complete reported quarters.

Ambev S.A. American Depositary Shares (Each representing 1 Common Share) Total Costs & Expenses — Trailing twelve months (TTM) (BRL)
Period endingTotal Costs & Expenses (BRL)
63,942,006,000
64,244,382,000
64,435,524,000
66,532,778,000
68,773,232,000
69,046,934,000
67,650,964,000
62,530,579,000
61,169,767,000
60,655,255,000
60,905,900,000
63,778,491,000
64,887,185,000
63,388,624,000
62,021,000,000
61,600,638,000
59,544,886,000
57,400,914,000
55,774,000,000
50,053,551,000
47,596,662,000
45,486,114,000
42,406,800,000
41,809,322,000
38,608,831,000
37,508,600,000
36,524,800,000
35,807,082,000
34,645,380,000
33,874,848,000
33,129,957,000
32,074,372,000
32,167,418,000
31,570,104,000
31,472,500,000
29,621,315,000
29,218,735,000
29,068,232,000
28,497,200,000
29,845,856,000
29,026,471,000
28,737,386,000
27,941,700,000
25,864,868,000
24,472,316,000
23,092,896,000
22,253,216,000
21,219,865,000
20,947,549,000
20,405,949,000
19,591,649,000
19,588,171,000
19,493,557,000
18,944,057,000
18,461,732,000
17,607,513,000
16,584,106,000
15,847,386,000
15,417,300,000
15,331,509,000
15,270,638,000
15,296,776,000
15,210,300,000
15,137,150,000
14,811,606,000
14,526,320,000
14,016,107,000
12,293,878,924
11,944,177,924
11,621,445,924
11,422,545,924
13,217,239,497
13,850,528,005
14,592,663,092
15,179,741,913
14,437,210,951
14,327,844,820
13,961,529,752
13,423,990,284
15,322,960,585
15,025,419,850
14,598,982,429
14,766,449,372
13,871,487,277
12,683,296,180
11,577,023,396
10,025,564,371
7,401,914,898
6,783,765,464
6,419,570,882
6,237,526,023
6,771,052,368
6,509,920,676
6,225,985,783
5,985,669,859
5,755,244,736
5,819,953,514
5,702,046,607
5,663,388,629
5,681,756,345
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.